BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines non-GAAP Free Cash Flow ($M) ($M)
Form 8-K EX-99.1 Non-GAAP Reconciliation Tables
Latest, Q2 2026
435
Period ended Jun 30, 2026
Change on a year earlier
+98.1%
220 in Q2 2025
History
9 quarters
Since Q2 2024
Sources
5
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Free Cash Flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 435 | +98.1% | Form 8-K (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 161 | -1,402.6% | Form 8-K (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 380 | -2,293.0% | Form 8-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 354 | +547.9% | Form 8-K (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 220 | -206.9% | Form 8-K (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | -12.3 | – | Form 8-K (filed 2026-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | -17.3 | – | Form 8-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 54.7 | – | Form 8-K (filed 2025-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | -206 | – | Form 8-K (filed 2025-08-06) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Non-GAAP Free Cash Flow ($M) ($M), quarterly Q2 2024–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/non_gaap_fcf
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.